High-flow nasal cannula for stabilisation of very premature infants: A prospective observational study
Language English Country Norway Media print-electronic
Document type Journal Article, Observational Study
Grant support
RVO-VFN64165
Všeobecná Fakultní Nemocnice v Praze
PubMed
39584601
PubMed Central
PMC11976121
DOI
10.1111/apa.17519
Knihovny.cz E-resources
- Keywords
- continuous positive airway pressure, delivery room, high‐flow nasal cannula, positive pressure ventilation, very premature infant,
- MeSH
- Cannula * MeSH
- Humans MeSH
- Infant, Extremely Premature * MeSH
- Infant, Premature MeSH
- Infant, Newborn MeSH
- Oxygen Inhalation Therapy * instrumentation methods MeSH
- Prospective Studies MeSH
- Feasibility Studies MeSH
- Continuous Positive Airway Pressure MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Infant, Newborn MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Observational Study MeSH
AIM: To assess the feasibility, safety and efficacy of using a high-flow nasal cannula (HFNC) for stabilising very preterm infants after birth. METHODS: A prospective observational study included preterm infants born at 28 + 0 to 31 + 6 weeks' gestation between February 2021 and December 2022 at the General University Hospital in Prague. Following delayed cord clamping, HFNC was administered at a flow rate of 8 L/min through the infants' nostrils. Criteria for switching to continuous positive airway pressure (CPAP) or positive pressure ventilation (PPV) included persistent bradycardia in the first few minutes or low saturation of oxygen (SpO2) after 5 min, respectively. RESULTS: Of the 65 infants enrolled in the study, 56 (86%) were successfully stabilised exclusively using HFNC while 7 (11%) required PPV. Additionally, 52 (80%) infants achieved SpO2 > 80% at 5 min, and 54 (83%) infants were successfully treated with HFNC within the first 3 h of life. CONCLUSION: The primary use of HFNC seems to be an appropriate alternative to CPAP for the stabilisation of very premature infants after birth and subsequent transfer to the NICU. A randomised trial comparing HFNC and CPAP in the delivery room will enable to answer the questions raised in this study.
See more in PubMed
Madar J, Roehr CC, Ainsworth S, et al. European resuscitation council guidelines 2021: newborn resuscitation and support of transition of infants at birth. Resuscitation. 2021;161:291‐326. PubMed
Kirpalani H, Ratcliffe SJ, Keszler M, et al. Effect of sustained inflations vs intermittent positive pressure ventilation on bronchopulmonary dysplasia or death among extremely preterm infants: the SAIL randomized clinical trial. JAMA. 2019;321:1165‐1175. PubMed PMC
Lista G, Cavigioli F, La Verde PA, Castoldi F, Bresesti I, Morley CJ. Effects of breathing and Apnoea during sustained inflations in resuscitation of preterm infants. Neonatology. 2017;111(4):360‐366. PubMed
Martherus T, Oberthuer A, Dekker J, et al. Supporting breathing of preterm infants at birth: a narrative review. Arch Dis Child Fetal Neonatal Ed. 2019;104:F102‐F107. PubMed
Kuypers K, Martherus T, Lamberska T, Dekker J, Hooper SB, Te Pas AB. Reflexes that impact spontaneous breathing of preterm infants at birth: a narrative review. Arch Dis Child Fetal Neonatal Ed. 2020;105:675‐679. PubMed
Kuypers KLAM, Hopman A, Cramer SJE, et al. Effect of initial and subsequent mask applications on breathing and heart rate in preterm infants at birth. Arch Dis Child Fetal Neonatal Ed. 2023;108(6):594‐598. PubMed
Reynolds P, Leontiadi S, Lawson T, Otunla T, Ejiwumi O, Holland N. Stabilisation of premature infants in the delivery room with nasal high flow. Arch Dis Child Fetal Neonatal Ed. 2016;101:F284‐F287. PubMed
Siva NV, Reynolds PR. Stabilisation of the preterm infant in the delivery room using nasal high flow: a 5‐year retrospective analysis. Acta Paediatr. 2021;110:2065‐2071. PubMed
Roberts CT, Hodgson KA. Nasal high flow treatment in preterm infants. Matern Health Neonatol Perinatol. 2017;6(3):15. PubMed PMC
Mazmanyan P, Darakchyan M, Pinkham MI, Tatkov S. Mechanisms of nasal high flow therapy in newborns. J Appl Physiol (1985). 2020;128(4):822‐829. PubMed PMC
Roehr CC, Yoder BA, Davis PG, Ives K. Evidence support and guidelines for using heated, humidified, high‐flow nasal Cannulae in neonatology: Oxford nasal high‐flow therapy meeting, 2015. Clin Perinatol. 2016;43(4):693‐705. PubMed
Foglia EE, Shah BA, Szyld E. Positive pressure ventilation at birth. Semin Perinatol. 2022;46:151623. PubMed
Diggikar S, Ramaswamy VV, Koo J, Prasath A, Schmölzer GM. Positive pressure ventilation in preterm infants in the delivery room: a review of current practices, challenges, and emerging technologies. Neonatology. 2024;1‐10:288‐297. PubMed
Tana M, Tirone C, Aurilia C, et al. Respiratory Management of the Preterm Infant: supporting evidence‐based practice at the bedside. Children (Basel). 2023;10(3):535. PubMed PMC
Norman E, Westrin P, Fellman V. Placental transfer and pharmacokinetics of thiopentone in newborn infants. Arch Dis Child Fetal Neonatal Ed. 2010;95:F277‐F282. PubMed
Bjorland PA, Øymar K, Ersdal HL, Rettedal SI. Incidence of newborn resuscitative interventions at birth and short‐term outcomes: a regional population‐based study. BMJ Paediatr Open. 2019;3:3. PubMed PMC
Roberts CT, Owen LS, Manley BJ, et al. Nasal high‐flow therapy for primary respiratory support in preterm infants. N Engl J Med. 2016;375:1142‐1151. PubMed
Manley BJ, Arnolda GRB, Wright IMR, et al. Nasal high‐flow therapy for newborn infants in special care nurseries. N Engl J Med. 2019;380:2031‐2040. PubMed